Danone (OTCMKTS:DANOY) Sees Strong Trading Volume – Here’s Why

Danone (OTCMKTS:DANOY) saw unusually-strong trading volume on Thursday . Approximately 642,175 shares traded hands during trading, an increase of 20% from the previous session’s volume of 536,475 shares.The stock last traded at $16.17 and had previously closed at $15.87.

Analyst Ratings Changes

DANOY has been the topic of a number of recent research reports. Royal Bank Of Canada reiterated a “sector perform” rating on shares of Danone in a research note on Wednesday, October 29th. Morgan Stanley restated an “overweight” rating on shares of Danone in a report on Friday, October 10th. Citigroup reiterated a “neutral” rating on shares of Danone in a report on Wednesday, October 29th. Finally, Deutsche Bank Aktiengesellschaft cut Danone from a “hold” rating to a “sell” rating in a research note on Monday, January 12th. Two research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Danone has an average rating of “Hold”.

Danone Stock Performance

The company’s fifty day moving average price is $17.87 and its 200-day moving average price is $17.35. The company has a current ratio of 0.95, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66.

Danone Company Profile

Danone is a French multinational food-products company headquartered in Paris, with roots dating to 1919 when it was founded by Isaac Carasso. The company positions itself around nutrition and health-oriented food and beverage products, and it combines global brand management, manufacturing and distribution to serve a broad consumer base. Danone’s long history has been characterized by expansion beyond its original yogurt business into bottled water, infant and medical nutrition, and plant-based alternatives.

Danone’s principal activities include the development, production and marketing of dairy and plant-based products, bottled waters, and specialized nutrition for infants and medical patients.